US-based biopharmaceutical company Nanotherapeutics has been acquired by Serum Institute of India.
Based in India, the acquirer company develops and manufactures drugs. Serum Institute has paid €45m ($48.85m) as an upfront payment for the €72m ($78.17m) acquisition, while the remaining consideration will be paid a year later.
The acquisition is expected to help the Indian company to create a unit for polio vaccine injectables.
German healthcare company Fresenius has reached an agreement to acquire Akorn for $4.3bn.
The acquirer company will also assume the target company’s net debt of approximately $450m.
See Also:
Akorn is a generic pharmaceutical company based in the US, whose acquisition is expected to complement Fresenius’ medicines division.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataNanoCarrier, a company based in Japan, is set to acquire US-based Tocagen.
Both companies involved in the acquisition are biotechnology firms.